2012 CMIO salary survey is now open!

Beth Walsh | | Health Exec | Compensation
Not titled - 11.58 Kb
CMIOs and other health IT leaders are invited to help CMIO compile a comprehensive view of the trends in the industry and the factors that are most important when determining salary and compensation by taking its annual 2012 CMIO Compensation Survey.

Individual answers will be kept confidential and will be used only in aggregate by CMIO for tabulating the results of this survey. The polling is open through Jan. 6, and only to health IT executives who work for healthcare organizations. The results will be published in the February magazine issue of CMIO and online at CMIO.net, and distributed at the HIMSS conference.

To take the survey, click here.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

UnitedHealth CEO defends company, plans to honor legacy of Brian Thompson
Cath lab techs and nurses see new normal with post-COVID pay
Challenges to the financial stability of the American healthcare system
Healthcare staffing shortages leading to financial instability
CMS proposes 2.8% pay cut for providers in 2025
AMA: Community practices unsustainable with low Medicare and Medicaid physician payments

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.